ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 128 filers reported holding ANIKA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $680,520 | -7.8% | 26,194 | +1.9% | 0.01% | 0.0% |
Q1 2023 | $737,960 | -6.2% | 25,695 | -3.3% | 0.01% | -16.7% |
Q4 2022 | $786,768 | +122258.9% | 26,580 | -1.7% | 0.01% | +20.0% |
Q3 2022 | $643 | -99.9% | 27,026 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $603,000 | -11.2% | 27,026 | 0.0% | 0.01% | +25.0% |
Q1 2022 | $679,000 | -35.3% | 27,026 | -7.8% | 0.00% | -33.3% |
Q4 2021 | $1,050,000 | -15.8% | 29,306 | 0.0% | 0.01% | -14.3% |
Q3 2021 | $1,247,000 | -1.7% | 29,306 | 0.0% | 0.01% | -12.5% |
Q2 2021 | $1,269,000 | +6.2% | 29,306 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $1,195,000 | -16.0% | 29,306 | -6.8% | 0.01% | -27.3% |
Q4 2020 | $1,423,000 | +25.9% | 31,446 | -1.5% | 0.01% | +22.2% |
Q3 2020 | $1,130,000 | -6.2% | 31,926 | 0.0% | 0.01% | -18.2% |
Q2 2020 | $1,205,000 | +30.6% | 31,926 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $923,000 | -44.2% | 31,926 | 0.0% | 0.01% | +10.0% |
Q4 2019 | $1,655,000 | -13.9% | 31,926 | -8.9% | 0.01% | -23.1% |
Q3 2019 | $1,923,000 | +50.7% | 35,026 | +11.5% | 0.01% | +30.0% |
Q2 2019 | $1,276,000 | +228.9% | 31,418 | +145.1% | 0.01% | +150.0% |
Q1 2019 | $388,000 | -10.0% | 12,818 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $431,000 | +0.9% | 12,818 | +26.7% | 0.00% | +33.3% |
Q3 2018 | $427,000 | +43.8% | 10,118 | +9.1% | 0.00% | +50.0% |
Q2 2018 | $297,000 | -35.6% | 9,271 | 0.0% | 0.00% | -33.3% |
Q1 2018 | $461,000 | -7.8% | 9,271 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $500,000 | -7.1% | 9,271 | 0.0% | 0.00% | +50.0% |
Q3 2017 | $538,000 | +44.6% | 9,271 | +22.8% | 0.00% | -33.3% |
Q2 2017 | $372,000 | -14.7% | 7,547 | -24.9% | 0.00% | -25.0% |
Q1 2017 | $436,000 | -11.4% | 10,047 | 0.0% | 0.00% | -20.0% |
Q4 2016 | $492,000 | +2.3% | 10,047 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $481,000 | -10.8% | 10,047 | 0.0% | 0.01% | -16.7% |
Q2 2016 | $539,000 | +20.0% | 10,047 | 0.0% | 0.01% | +20.0% |
Q1 2016 | $449,000 | +17.2% | 10,047 | 0.0% | 0.01% | +66.7% |
Q4 2015 | $383,000 | -25.5% | 10,047 | -37.8% | 0.00% | -40.0% |
Q3 2015 | $514,000 | -31.9% | 16,147 | -29.3% | 0.01% | 0.0% |
Q2 2015 | $755,000 | -34.6% | 22,847 | -18.5% | 0.01% | -44.4% |
Q1 2015 | $1,155,000 | +4.2% | 28,047 | +3.1% | 0.01% | +28.6% |
Q4 2014 | $1,108,000 | +11.1% | 27,197 | 0.0% | 0.01% | 0.0% |
Q3 2014 | $997,000 | -16.9% | 27,197 | +5.0% | 0.01% | 0.0% |
Q2 2014 | $1,200,000 | +28.1% | 25,897 | +13.6% | 0.01% | +16.7% |
Q1 2014 | $937,000 | -11.0% | 22,800 | -17.4% | 0.01% | -14.3% |
Q4 2013 | $1,053,000 | – | 27,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |